INTS
Intensity Therapeutics, Inc. Common stock
NASDAQ: INTS · HEALTHCARE · BIOTECHNOLOGY
$5.21
+0.06% today
Updated 2026-05-06
Market cap
$13.80M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.56
Dividend yield
—
52W range
$5 – $44
Volume
0.0M
Intensity Therapeutics, Inc. Common stock (INTS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.42M | $-5.37M | $-6.83M | $-5.48M | $-7.21M | $-15.22M | $-9.23M |
| Capital expenditures | $0.00 | $0.00 | $3.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | $179037.00 | $147000.00 | — | — |
| Stock-based comp | $561377.00 | $555488.00 | $719822.00 | $1.17M | $1.40M | $3.07M | $2.00M |
| Free cash flow | $-4.42M | $-5.37M | $-6.83M | $-5.48M | $-7.21M | $-15.22M | $-9.23M |
| Investing cash flow | $1.70M | $4.56M | — | — | $-6.02M | $6.35M | — |
| Financing cash flow | $3.86M | $6.29M | $2.05M | $2.25M | $20.47M | $2.90M | — |
| Dividends paid | — | — | — | — | $1.32M | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |